REG - Judges ScientificPLC - Acquisition of Heath Scientific Company Limited

Judges ScientificAnnouncement

29/05/2020 07:01

RNS Number : 2919O
  
Judges Scientific PLC
  
29 May 2020
  
 





Press Release


29 May 2020




Judges Scientific plc
("Judges Scientific", "Judges", the "Company" or the "Group")
Acquisition of Heath Scientific Company Limited
Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces that it has acquired today the entire issued share capital of Heath Scientific Company Limited ("Heath" or the "Acquisition"), a world leading maker of calorimetry instruments. The Board expects the Acquisition to be immediately earnings enhancing.  
The initial consideration for Heath is £5.3 million in cash. The consideration for the Acquisition has been financed from the Group's £35 million acquisition facility from Lloyds Bank Corporate Markets.  
Information and rationale for the Acquisition
Heath, through its subsidiaries Thermal Hazard Technology Limited and THT Inc., specialises in the design, manufacture and sale of instruments used to measure the thermal properties of lithium batteries and other reactive materials. Its main product, the Accelerating Rate Calorimeter, is a key tool to improve and verify the safety of lithium batteries and of other chemical reactions. This is an expanding market in light of the growth in the use of lithium batteries in electronic devices and electric vehicles.
The science underlying Heath's products is similar to the scientific fundamentals of Fire Testing Technology, the Group's first acquisition in May 2005. In addition, the aim of both companies is to improve the safety of the products manufactured by their customers. The Board believes the interaction between the two companies will be constructive.
Heath, based in Bletchley, Buckinghamshire, was established in 1994 by Martyn Ottaway (the Managing Director) and Phill O'Kane (the Sales and Marketing Director); they were joined in 1996 by Stelios Mores, the R&D Director. The founders, in some cases with their families, each owned approximately one third of the shares in Heath. Following the acquisition Martyn will retire but remain on the board of Heath as a non-executive director; his son Stephen, the Business Development Director, recently joined Phill and Stelios on the board and the three will lead the company in the future.
Heath's accounts for the financial year to 30 April 2019 show revenues of £4.4 million and pre-tax profits of £0.7 million.  Net tangible assets amounted to £1.9 million, including cash of £0.8 million.  Heath's operating profit for the year ended 30 April 2019, adjusted to eliminate non-recurring items and to reflect Heath's ongoing cost base within Judges, would have totalled £879,000. 
Terms of the Acquisition
The purchase price of Heath consists of the following:
·     The initial price, paid in cash at completion, amounting to £5.3 million; 
·   Potential further contingent consideration of up to a maximum £2.0 million in aggregate ("Earn-out Consideration") to be satisfied in cash.
The Earn-out Consideration will be payable if and to the extent that Heath's adjusted EBIT in the financial year to 30 April 2020 or in the 12-month period to 31 December 2020 exceeds £879,000.  The Earn-out Consideration may be payable in two tranches and the maximum earn-out would be payable if, in either period, adjusted EBIT exceeds £1.22 million.
An additional payment will also be due if there is an excess cash balance over and above the ongoing requirements of the business.  The Board expects any such payment to be covered by the cash inherited at the completion date. 
Alex Hambro, Chairman of Judges, said:
"Heath is a world leading business in a focused global niche, selling quality products which are indispensable to the safety of the public. This cash generative and earnings enhancing acquisition fits within the Judges disciplined acquisition strategy.  We are delighted to welcome Phill, Stelios and Stephen and all their colleagues to Judges' family."
 
For further information please contact:




Judges Scientific


 


 




David Cicurel, CEO
Brad Ormsby, Group FD


Tel: +44 (0) 20 3829 6970


 




 
Shore Capital (Nominated Adviser & Joint Broker)


 




Stephane Auton
Edward Mansfield
Sarah Mather


Tel: +44 (0) 20 7408 4090




 


 




     Liberum (Joint Broker)
     Bidhi Bhoma
     Euan Brown


 
Tel:  +44 (0) 20 3100 2222




 
Media enquiries:
Alma PR (Financial Public Relations)


 




Rebecca Sanders-Hewett
Sam Modlin
 


Tel: +44 (0) 20 3405 0205
judges@almapr.co.uk




 
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group now consists of 18 businesses acquired since it was re-admitted to AIM in 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group companies hold five Queen's Awards for innovation and export.  
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the repayment of debt, organic growth and dividends.  
For further information, please visit www.judges.uk.com
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ACQKZGZKLRDGGZM